title: Protection against ethanol injury by prostaglandin in a human intestinal cell line: role of microtubules.
abstract: Prostaglandins have been shown to protect the gastrointestinal (GI) epithelium from injury induced by various luminal insults independent of their known acid-inhibitory effects, a process termed "cytoprotection." The mechanism of this protective action remains unknown. The present investigation determined the role of microtubules (a major cytoskeletal component) in GI injury induced by ethanol (EtOH) and its prevention by 16,16-dimethylprostaglandin E2 (dmPGE2) using cells from a human colonic cell line known as Caco-2 cells. These cells were preincubated in Eagle's minimum essential medium with and without dmPGE2 (2.6 microM) for 15 min and subsequently incubated in media containing 1, 2.5, 5, 7.5, and 10% EtOH. The effects on cell viability and tubulin (the major protein backbone of microtubules) were then determined. EtOH concentrations > or = 2.5% extensively disrupted the microtubules as demonstrated by fragmentation, kinking, and perturbation of the microtubule organizer center. EtOH treatment also led to a significant decrease in the S2 (polymerized) fraction and an increase in the S1 (monomeric) pool of tubulin. Concomitant with these effects were marked decreases in cellular viability. DmPGE2 pretreatment abolished the disruption of microtubules, significantly increased the S2 fraction of tubulin, and increased cellular viability in cultures exposed to EtOH. Furthermore, pretreatment with colchicine, an inhibitor of microtubule assembly, prevented the cytoprotective action of dmPGE2. Taxol, a microtubule stabilizing agent, mimicked the effects of dmPGE2 by also enhancing microtubule integrity and increasing cellular viability in cells exposed to EtOH. Our data indicate that organization and stabilization of microtubules may play an essential role in the mechanism of prostaglandin-induced protection.
authors.affiliation: Theodore Cooper Surgical Research Institute, Department of Surgery, Saint Louis University Medical Center, Missouri 63104, USA.
authors.forename: A
authors.initials: A
authors.lastname: Banan
authors.forename: G S
authors.initials: GS
authors.lastname: Smith
authors.forename: C L
authors.initials: CL
authors.lastname: Rieckenberg
authors.forename: E R
authors.initials: ER
authors.lastname: Kokoska
authors.forename: T A
authors.initials: TA
authors.lastname: Miller
mesh_terms: D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003078:Colchicine / Q000494:pharmacology; D003106:Colon; D003110:Colonic Neoplasms; D000431:Ethanol / Q000037:antagonists & inhibitors / Q000633:toxicity*; D006801:Humans; D008870:Microtubules / Q000187:drug effects / Q000502:physiology*; D017239:Paclitaxel / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D000897:Anti-Ulcer Agents; D000431:Ethanol; D015064:16,16-Dimethylprostaglandin E2; D017239:Paclitaxel; D003078:Colchicine